Noah M. Hahn, MD was born in Valparaiso, Indiana and attended the University of Notre Dame where he graduated in 1994 with a degree in mechanical engineering. He finished his medical school training at the Indiana University School of Medicine in 2000. He completed a transitional year internship at Emory University in 2001, his internal medicine residency at Duke University in 2003, and his hematology and oncology fellowship at the Indiana University Simon Cancer Center (IUSCC) in 2006. Upon completion of his fellowship training, he was appointed to the IUSCC oncology faculty and served as the leader of their prostate and bladder cancer programs. In addition, he served as the chief scientific officer of the Hoosier Cancer Research Group (formerly the Hoosier Oncology Group) and the executive officer of the Big Ten Cancer Research Consortium. In April 2014, Dr. Hahn joined the Johns Hopkins University School of Medicine faculty as the director of the medical oncology bladder cancer program with the academic rank of associate professor of oncology and urology.
Dr. Hahn is an internationally recognized authority in the conduct of bladder cancer novel therapeutic clinical trials and translational investigations. He maintains an active clinical practice and sees patients with urothelial cancers of all locations and stages including non-muscle invasive bladder cancer. He is one of the few oncologists in the world leading a clinical trial in non-muscle invasive bladder cancer. In addition, Dr. Hahn continues to care for patients with non-urothelial genitourinary malignancies including prostate, testicular, and other rare tumors. Dr. Hahn's clinical and translational research interests focus on improving outcomes for patients with urothelial cancers through:
In addition to his efforts at Johns Hopkins, Dr. Hahn serves as the bladder cancer chairman of the Eastern Cooperative Oncology Group (ECOG), co-chairs the Hoosier Cancer Research Network genitourinary oncology clinical trials working group, participates on the NCI Bladder Cancer Task Force, and serves on the scientific advisory board of the Bladder Cancer Advocacy Network.
1994 Cum Laude B.S., Mechanical Engineering, University of Notre Dame, Notre Dame, IN
2000 M.D., Indiana University School of Medicine, Indianapolis, IN
6/00 – 6/01 Transitional Year Internship, Emory University, Atlanta, GA
7/01 – 7/03 Internal Medicine Residency, Duke University, Durham, NC
7/03 – 6/06 Hematology and Oncology Fellowship, Indiana University School of Medicine, Indianapolis, IN
8/06 – 6/08 Clinical Investigator Training Enhancement Program (9 credit hours – Bioethics, Biostatistics, Clinical Trial Design),
Indiana University School of Medicine, Indianapolis, IN
Free Access to abstracts at PubMed
Peer-Reviewed Original Science Research Publications